FTC sues major pharmacy profit administrators over insulin prices The company introduced motion from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the listing cost of lifestyle-conserving insulin medications. The deal has to be finished by Sept. thirty or prospective buyers can terminate https://buschlightpeachnutritionf50594.blogsvila.com/30755584/not-known-factual-statements-about-healthcare-news